Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Tefinostat |
Synonyms | |
Therapy Description |
Tefinostat (CHR-2845) is a monocyte/macrophage targeted HDAC inhibitor, which may result in decreased proliferation of hCE1-expressing hematological tumor cells (PMID: 23647373). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tefinostat | CHR-2845|CHR 2845|CHR2845 | HDAC Inhibitor 45 | Tefinostat (CHR-2845) is a monocyte/macrophage targeted HDAC inhibitor, which may result in decreased proliferation of hCE1-expressing hematological tumor cells (PMID: 23647373). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|